https://azd2281inhibitor.com/a....lterations-in-mobile
Where readily available, pre-CRT examples had been tested for PD-L1 phrase (immunohistochemistry) and scored at pre-specified (25%) and post-hoc (1%) TC cutoffs. Treatment-effect HRs were expected from unstratified-Cox-proportional-hazards models (Kaplan-Meier-estimated medians). RESULTS 709/713 randomised patients got durvalumab (n=473) or placebo (n=236). 451 (63%) were PD-L1-
Like
Comment
Share
